All Convenzis Events Provide 8 CPD Points Per Delegate
Delivered in partnership by Convenzis Group and Healthcare Innovation Consortium.
Take part in our conference prize draw by visiting all stands and scanning your lanyard at each for a chance to win £100 voucher.
Current Landscape and Challenges:
Genomics is rapidly transitioning from specialist research environments into routine NHS clinical care. Through the NHS Genomic Medicine Service, genomic testing is increasingly embedded across cancer pathways, rare disease diagnostics, pharmacogenomics and personalised treatment decision-making.
From April, the NHS moves into a new phase of delivery where genomic laboratories and the wider Genomic Medicine Service operate as a single integrated national model, designed to support genomic testing at scale across the health system.
However, while national infrastructure and testing capability have advanced significantly, many NHS organisations are now facing the practical challenge of integrating genomic medicine into everyday clinical workflows.
Key challenges include:
As genomic testing becomes part of routine care pathways, success will depend not only on national infrastructure, but on how effectively genomic services integrate into frontline clinical delivery across the NHS.
Importance and Timeliness of the Event:
The NHS is entering a critical implementation phase for genomic medicine.
Over the next three years, the focus will shift from building genomic infrastructure toward making the unified Genomic Medicine Service fully operational across clinical pathways.
This means solving practical challenges around digital connectivity, test ordering, reporting, interpretation and workforce capability. Interoperability between genomic systems, laboratories and clinical environments will be essential to ensure genomic insights can be used safely and effectively in patient care.
At the same time, clinicians across specialties are increasingly expected to incorporate genomic insights into diagnosis, treatment selection and personalised care planning.
This conference provides a focused forum for NHS leaders to explore how genomic medicine is being operationalised today, sharing real-world lessons from national programmes, genomic service leaders and NHS organisations integrating genomics into routine care.
Summit Focus:
GenomicsConnect 2026 is a skills-led summit focused on the operational delivery of genomic medicine across the NHS.
The programme concentrates on the practical challenges organisations face as genomics becomes embedded in mainstream healthcare, including:
Sessions combine national strategic insight with practical implementation experiences from NHS genomic programme leaders, digital architects, clinicians and service transformation leads.
Key Themes:
We have an invite only option for NHS Senior Managers for our conference, to see if you qualify for a complimentary place please click the button below.
Registration & Networking
Registration - Open from 8:20 am - Closes at 11:00 am
All delegates must complete their registration process before the 11:00 AM cut-off time. Please arrive in a timely manner to allow for registration and to avoid any inconvenience. Delegates who arrive after the registration deadline will be refused entry to the event.
We appreciate your cooperation in helping us maintain the event's schedule and ensuring that everyone can fully participate in the conference. If you have any questions or require assistance, our event staff will be available to assist you with the registration process.
Thank you for your understanding, and we look forward to an insightful and productive event together!
Keynote Presentation (TBC)
Session TBC
Morning Skill Clinic (TBC)
Session TBC
Main Sponsor
Main Sponsor
Case Study - C the Signs
Case Study - C the Signs
C the Signs is an AI-driven platform, created by NHS doctors, that leverages cutting-edge data analytics to detect cancer early: when it is most treatable.
Implemented in primary care, C the Signs analyses patient-reported data and electronic health records to identify patients at risk of cancer, determine the type of cancer, and guide healthcare professionals to the appropriate diagnostic or referral pathway.
C the Signs has already detected cancer in over 50,000 patients, spanning more than 50 cancer types, including rare and hard-to-detect cancers. With 99% sensitivity, 99% negative predictive value, and 94% accuracy in predicting tumour origin, it is transforming how cancer is diagnosed and treated.
This year, we’ve expanded the scope of our impact with the launch of C my Signs in the NHS. C my Signs empowers patients to use self-assessments for direct referrals, in collaboration with hospitals and diagnostic hubs, increasing the patient touchpoints that can lead to earlier detection.
C the Signs is a UKCA-marked Class I medical device, fully integrated with electronic health records and compliant with the highest security standards. It has been implemented across 1,600 GP practices in England, in partnership with Integrated Care Boards and Cancer Alliances.
Case Study
Case Study
Leadership Lessons from the Front Line (TBC)
Session TBC
Case Study
Case Study
Case Study
Case Study
NHS Deep Dive (TBC)
Session TBC
Case Study
Case Study
NHS Deep Dive (TBC)
Session TBC
Afternoon Skill Clinic (TBC)
Session TBC
Breakout Skill Clinic (TBC)
Session TBC